Medical device company Cooper Companies Inc. (COO) Monday announced that CooperSurgical has acquired Wallace, the in-vitro fertilization or IVF segment of Smiths Medical, a division of Smiths Group plc (SMIN.L). The purchase price is approximately $168 million subject to customary closing adjustments.
In the last twelve months, Wallace reported sales of approximately $29 million. Excluding non-recurring items and deal-related amortization, the transaction is expected to be approximately $0.10 accretive to earnings per share in fiscal 2017.
Robert Weiss, Cooper's president and chief executive officer said, "This acquisition is a great strategic fit with our existing IVF portfolio as Wallace brings the gold standard of embryo transfer catheters along with several other premier products such as oocyte retrieval needles. The addition of these products further strengthens our IVF portfolio which is sold into fertility clinics worldwide."
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.